Retinoid X receptor agonists enhances type I systemic and intratumoral immunity, but enhanced tumor prevention, with the HER2-IGFBP2-IGF1R plasmid vaccine in two mouse mammary tumor models
Document Type
Abstract
Publication Date
11-1-2023
Keywords
oregon; chiles
Clinical Institute
Cancer
Clinical Institute
Women & Children
Department
Oncology
Recommended Citation
Stanton, Sasha and See full list of authors in comments, "Retinoid X receptor agonists enhances type I systemic and intratumoral immunity, but enhanced tumor prevention, with the HER2-IGFBP2-IGF1R plasmid vaccine in two mouse mammary tumor models" (2023). Articles, Abstracts, and Reports. 8367.
https://digitalcommons.providence.org/publications/8367
Comments
Stanton SE, Erin R, Drovetti N, Corulli L, Atigadda V, Grubbs C, Sei S, Disis ML. SITC Annual Meeting; November 1-5; San Diego, CA. 2023: 834.